2000
DOI: 10.5858/2000-124-0907-cpahto
|View full text |Cite
|
Sign up to set email alerts
|

Composite Prolymphocytoid and Hodgkin Transformation of Chronic Lymphocytic Leukemia

Abstract: The indolent course of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is occasionally altered by transformation to a histologically distinct, rapidly progressive, and clinically unresponsive hematologic malignant neoplasm. We report a case of CLL that, after 3 years of slowly progressive disease and treatment with single-agent chemotherapy (fludarabine phosphate), underwent a composite prolymphocytoid and classic Hodgkin lymphoma transformation. The diagnosis of classic Hodgkin lymphoma was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Among the remaining 99 articles, 26 were excluded from the final analysis because they met at least one exclusion criterion: (i) six NLPHL/NHL composite lymphomas without cHL contingent [ 27 , 28 , 29 , 30 , 31 , 32 ]; (ii) two cHL with an Epstein–Barr virus (EBV) post-transplant lymphoproliferative disorder [ 33 ] or EBV mucocutaneous ulcer [ 34 ]; (iii) one with CD30 negative Hodgkin cells [ 35 ]; (iv) four with Hodgkin-like cells within an NHL [ 36 , 37 , 38 , 39 ]; (v) two sequential lymphomas [ 40 , 41 ]; (vi) ten probable transformations of CCL into cHL [ 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ]; and (vii) one because the final diagnosis could be considered ambiguous [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…Among the remaining 99 articles, 26 were excluded from the final analysis because they met at least one exclusion criterion: (i) six NLPHL/NHL composite lymphomas without cHL contingent [ 27 , 28 , 29 , 30 , 31 , 32 ]; (ii) two cHL with an Epstein–Barr virus (EBV) post-transplant lymphoproliferative disorder [ 33 ] or EBV mucocutaneous ulcer [ 34 ]; (iii) one with CD30 negative Hodgkin cells [ 35 ]; (iv) four with Hodgkin-like cells within an NHL [ 36 , 37 , 38 , 39 ]; (v) two sequential lymphomas [ 40 , 41 ]; (vi) ten probable transformations of CCL into cHL [ 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ]; and (vii) one because the final diagnosis could be considered ambiguous [ 52 ].…”
Section: Resultsmentioning
confidence: 99%